As of October 2015 - States That Have Approved Medical Marijuana for Parkinson’s Disease
Currently, 10 states have approved medical marijuana for the treatment of Parkinson’s disease. These states include Connecticut, Georgia, Illinois, Maine, Massachusetts, New Hampshire, New Mexico, New York, Ohio and Pennsylvania.A number of other states will consider allowing medical marijuana to be used for the treatment of Parkinson’s disease with the recommendation from a physician. These states include: California (any debilitating illness where the medical use of marijuana has been recommended by a physician), Nevada (other conditions subject to approval), Oregon (other conditions subject to approval), Rhode Island (other conditions subject to approval), and Washington (any “terminal or debilitating condition”).
In Washington D.C., any condition can be approved for medical marijuana as long as a DC-licensed physician recommends the treatment.
In addition, several states have approved medical marijuana specifically to treat “chronic pain,” a symptom that can arise in people with Parkinson’s. These states include: Alaska, Arizona, California, Colorado, Delaware, Hawaii, Maine, Maryland, Michigan, Montana, New Mexico, Ohio, Oregon, Pennsylvania, Rhode Island and Vermont. The states of Nevada, New Hampshire, Ohio and Vermont allow medical marijuana to treat “severe pain.” The states of Minnesota, Ohio, Pennsylvania and Washington have approved cannabis for the treatment of “intractable pain.”
Also, 17 states have approved medical marijuana specifically for the treatment of nausea, which can develop from medications used to treat Parkinson’s. These states include: Alaska, Arizona, California, Colorado, Delaware, Hawaii, Maine, Maryland, Michigan, Montana, Nevada, New Hampshire, New Mexico, Oregon, Rhode Island, Vermont, and Washington.
Source: Medical Marijuana Inc
Effects of cannabidiol in the treatment of patients with Parkinson's disease: an exploratory double-blind trial. https://www.ncbi.nlm.nih.gov/pubmed/25237116
Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: an open-label observational study. https://www.ncbi.nlm.nih.gov/pubmed/24614667
Studies on Cannabis and Parkinson's Disease
Study Name, Description & Year
Potential Of The Cannabinoid CB(2) Receptor As A Pharmacological Target Against Inflammation In Parkinson's Disease
Animal study (mice) — 2016
Animal study (mice) — 2016
Cannabinoid-dopamine Interactions In The Physiology And Physiopathology Of The Basal Ganglia
Review — 2016
Review — 2016
Amyloid Proteotoxicity Initiates An Inflammatory Response Blocked By Cannabinoids
Laboratory Study — 2016
Laboratory Study — 2016
Fatty Acid Amide Hydrolase Inhibition For The Symptomatic Relief Of Parkinson's Disease
Animal study (mice) — 2016
Animal study (mice) — 2016
Treatment Of A Hyperkinetic Movement Disorder During Pregnancy With Dronabinol
Human case study — 2009
Human case study — 2009
Survey On Cannabis Use In Parkinson's Disease: Subjective Improvement Of Motor Symptoms
Patients with Parkinson's — 2004
Patients with Parkinson's — 2004
